Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Novel perspectives on the transcytotic route in osteoclasts.

Hirvonen MJ, Fagerlund K, Lakkakorpi P, Väänänen HK, Mulari MT.

Bonekey Rep. 2013 Mar 13;2:306. doi: 10.1038/bonekey.2013.40. eCollection 2013.

2.

Osteoclast ruffled border has distinct subdomains for secretion and degraded matrix uptake.

Mulari MT, Zhao H, Lakkakorpi PT, Väänänen HK.

Traffic. 2003 Feb;4(2):113-25.

3.

PYK2 autophosphorylation, but not kinase activity, is necessary for adhesion-induced association with c-Src, osteoclast spreading, and bone resorption.

Lakkakorpi PT, Bett AJ, Lipfert L, Rodan GA, Duong LT.

J Biol Chem. 2003 Mar 28;278(13):11502-12. Epub 2003 Jan 3.

4.

Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway.

Virtanen SS, Väänänen HK, Härkönen PL, Lakkakorpi PT.

Cancer Res. 2002 May 1;62(9):2708-14.

5.

Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells.

Ruohola JK, Viitanen TP, Valve EM, Seppänen JA, Loponen NT, Keskitalo JJ, Lakkakorpi PT, Härkönen PL.

Cancer Res. 2001 May 15;61(10):4229-37.

6.

Abnormal localisation and hyperclustering of (alpha)(V)(beta)(3) integrins and associated proteins in Src-deficient or tyrphostin A9-treated osteoclasts.

Lakkakorpi PT, Nakamura I, Young M, Lipfert L, Rodan GA, Duong LT.

J Cell Sci. 2001 Jan;114(Pt 1):149-160.

7.

Inhibition of osteoclast function by adenovirus expressing antisense protein-tyrosine kinase 2.

Duong LT, Nakamura I, Lakkakorpi PT, Lipfert L, Bett AJ, Rodan GA.

J Biol Chem. 2001 Mar 9;276(10):7484-92. Epub 2000 Dec 1.

8.

Integrins and signaling in osteoclast function.

Duong LT, Lakkakorpi P, Nakamura I, Rodan GA.

Matrix Biol. 2000 May;19(2):97-105. Review.

PMID:
10842093
9.

Role of alpha(v)beta(3) integrin in osteoclast migration and formation of the sealing zone.

Nakamura I, Pilkington MF, Lakkakorpi PT, Lipfert L, Sims SM, Dixon SJ, Rodan GA, Duong LT.

J Cell Sci. 1999 Nov;112 ( Pt 22):3985-93.

10.

Stable association of PYK2 and p130(Cas) in osteoclasts and their co-localization in the sealing zone.

Lakkakorpi PT, Nakamura I, Nagy RM, Parsons JT, Rodan GA, Duong LT.

J Biol Chem. 1999 Feb 19;274(8):4900-7.

11.
12.
13.

Phosphatidylinositol 3-kinase association with the osteoclast cytoskeleton, and its involvement in osteoclast attachment and spreading.

Lakkakorpi PT, Wesolowski G, Zimolo Z, Rodan GA, Rodan SB.

Exp Cell Res. 1997 Dec 15;237(2):296-306.

PMID:
9434625
14.

Beta 1 integrins and osteoclast function: involvement in collagen recognition and bone resorption.

Helfrich MH, Nesbitt SA, Lakkakorpi PT, Barnes MJ, Bodary SC, Shankar G, Mason WT, Mendrick DL, Väänänen HK, Horton MA.

Bone. 1996 Oct;19(4):317-28.

PMID:
8894137
15.
16.

Cytoskeletal changes in osteoclasts during the resorption cycle.

Lakkakorpi PT, Väänänen HK.

Microsc Res Tech. 1996 Feb 1;33(2):171-81. Review.

PMID:
8845516
17.

Isolation and characterization of highly enriched, prefusion mouse osteoclastic cells.

Wesolowski G, Duong LT, Lakkakorpi PT, Nagy RM, Tezuka K, Tanaka H, Rodan GA, Rodan SB.

Exp Cell Res. 1995 Aug;219(2):679-86.

PMID:
7641819
18.

Effects of recombinant human osteogenic protein-1 on the differentiation of osteoclast-like cells and bone resorption.

Hentunen TA, Lakkakorpi PT, Tuukkanen J, Lehenkari PP, Sampath TK, Väänänen HK.

Biochem Biophys Res Commun. 1995 Apr 17;209(2):433-43.

PMID:
7733910
19.
20.

Mitochondrial carbonic anhydrase in osteoclasts and two different epithelial acid-secreting cells.

Karhukorpi EK, Lakkakorpi P, Carter N, Dodgson S, Väänänen K.

Histochem J. 1992 Jan;24(1):9-14.

PMID:
1551800
21.

Vitronectin receptor has a role in bone resorption but does not mediate tight sealing zone attachment of osteoclasts to the bone surface.

Lakkakorpi PT, Horton MA, Helfrich MH, Karhukorpi EK, Väänänen HK.

J Cell Biol. 1991 Nov;115(4):1179-86.

22.

Inhibition of bone resorption by a monoclonal antibody that reacts with a 150 kD membrane protein in chicken osteoclasts.

Hentunen TA, Lakkakorpi PT, Rautiala T, Väänänen HK.

J Bone Miner Res. 1991 Oct;6(10):1091-7.

PMID:
1724590
23.

Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro.

Lakkakorpi PT, Väänänen HK.

J Bone Miner Res. 1991 Aug;6(8):817-26.

PMID:
1664645
24.
25.

Evidence for the presence of a proton pump of the vacuolar H(+)-ATPase type in the ruffled borders of osteoclasts.

Väänänen HK, Karhukorpi EK, Sundquist K, Wallmark B, Roininen I, Hentunen T, Tuukkanen J, Lakkakorpi P.

J Cell Biol. 1990 Sep;111(3):1305-11.

26.

Inhibition of osteoclast proton transport by bafilomycin A1 abolishes bone resorption.

Sundquist K, Lakkakorpi P, Wallmark B, Väänänen K.

Biochem Biophys Res Commun. 1990 Apr 16;168(1):309-13.

PMID:
2139331
27.

Organization of osteoclast microfilaments during the attachment to bone surface in vitro.

Lakkakorpi P, Tuukkanen J, Hentunen T, Järvelin K, Väänänen K.

J Bone Miner Res. 1989 Dec;4(6):817-25.

PMID:
2692403
28.

Mechanism of osteoclast mediated bone resorption.

Väänänen HK, Hentunen T, Lakkakorpi P, Parvinen EK, Sundqvist K, Tuukkanen J.

Ann Chir Gynaecol. 1988;77(5-6):193-6. Review.

PMID:
3076045

Supplemental Content

Loading ...
Support Center